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Surface plasmon resonance 
based sensor for the detection of 
glycopeptide antibiotics in milk 
using rationally designed nanoMIPs
Zeynep Altintas
Glycopeptide antibiotics are known as the last resort for the treatment of serious infections caused by 
Gram-positive bacteria. The use of milk products contaminated with these antibiotic residues leads to 
allergic reactions and sensitivity in human. Also, long-term consumption of milk products containing 
low levels of these antibiotics may cause the relevant bacteria to build up resistance to these last resort 
antibiotics. Sensitive, rapid and effective quantification and monitoring systems play a key role for 
their determination in milk products. Hence, molecularly imprinted nanostructures were rationally 
designed in this work to produce high affinity synthetic receptors to be coupled with a surface plasmon 
resonance sensor for the analysis of glycopeptide antibiotics in milk samples. The nanoMIP-SPR sensor 
enabled vancomycin quantification with the LODs of 4.1 ng mL−1 and 17.7 ng mL−1 using direct and 
competitive assays, respectively. The recoveries rates for two sensor methods ranged in 85–110% with 
RSDs below 7%. The affinity between the nanoMIP receptors and the target molecule (dissociation 
constant: 1.8 × 10−9 M) is mostly superior to natural receptors and other synthetic receptors. Unlike 
other methods commonly employed for the detection of milk contaminants this approach is extremely 
simple, fast and robust, and do not require pre-sample treatment.
Glycopeptide antibiotics are known as the last resort for the treatment of life-threatening diseases caused by 
Gram-positive bacteria, such as Clostridium difficile, Enterococcus spp. and Staphylococcus aureus. Various 
groups of soil actinomycetes are responsible from the production of these glycosylated non-ribosomal peptides. 
Glycopeptide antibiotics target Gram-positive bacteria by binding to the acyl-d-alanyl-d-alanine (d-Ala-d-Ala) 
terminus of the growing peptidoglycan on the outer cell membrane surface. Microorganisms gained resistance to 
these glycopeptides avoid such a fate by replacing the d-alanyl-d-serine (d-Ala-d-Ser) or d-Ala-d-Ala terminus 
with d-alanyl-d-lactate (d-Ala-d-Lac), thus notably lowering antibiotic affinity for the cellular target. The use of 
antibiotics on farm animals may cause allergic reactions and chemical poisoning leading to the transfer of these 
compounds into to food chain1. The overuse of antibiotics can result in the development of bacterial resistance 
causing insufficient or unsuccessful treatment of human or animal diseases2,3. The presence of these pharma-
ceuticals in milk also affects the fermentation process and this has resulted in intensive regulations on milk to 
protect public health4. Maximum residue levels (MRLs) of antibiotics allowed to be found in milk are in trace 
amounts that range in 10–200 µg kg−1 5. There is a need to develop highly sensitive quantification methods that 
should also be rapid, easy-to-use and reliable. Several techniques exist for pharmaceuticals’ determination such as 
spectroscopy6,7, liquid chromatography-mass spectroscopy (LC-MS)8,9, high performance liquid chromatography 
(HPLC)10,11, capillary electrophoresis12 and sensors5,9,13–15. Sensor technologies offer clear advantageous when 
compared to the other methods such as easy handling, rapid analysis without pre-sampling, and high sensitivity 
of assay platforms that allow detecting trace amounts of antibiotics in milk. Effective detection principles using 
different sensor systems have been reported for pharmaceutical quantification and monitoring9,13,15,16. The inte-
gration of nano-molecularly imprinted polymers (nanoMIPs) as synthetic affinity receptors into sensor devices 
has made a significant contribution to the bio-detection field. NanoMIPs produced using a solid phase has been 
pioneered by our group9,17,18 and the solid phase synthesis approach demonstrates superior advantages over the 
other MIP synthesis methods17–21: Low affinity polymers can be discarded during the manufacturing process by 
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applying cold wash (1), high affinity nanoMIPs are collected by performing elution steps at high temperature 
(2), the template free receptors are obtained with this method, because nanoMIPs are removed from the tem-
plate molecule rather than the template being removed from the MIP (3), the stability and size of the nanoMIPs 
are high owing to the selective washing and elution steps (4), a significant amount of MIPs can be obtained per 
synthesis that is adequate for long term experiments (5)17–21. These superior features have resulted in the success-
ful applications of nanoMIPs in various fields such as pharmaceutical monitoring9,13, virus quantification18,21, 
endotoxin detection22,23, development of enzyme linked immonosorbent assays (ELISA)24,25, manufacturing of 
bioselective membrane filters11, and in vivo recognition of biomarkers26.
The current work aims to extend the applications of nanoMIPs in food samples analysis to determine the 
presence of glycopeptide antibiotics in milk. NanoMIPs targeting vancomycin as a natural glycopeptide were 
therefore rationally designed by employing computational simulations and they were synthesized using the best 
polymer composition. The synthetic receptors were then used for the construction of an optical sensor for the 
sensitive detection of vancomycin in milk samples. To the best of our knowledge this is the first computationally 
designed nanoMIP for milk sample analysis using sensors. More importantly, this work provides the most sensi-
tive and rapid analysis using the nanoMIP receptors and it introduces two different sensor assays to effective milk 
sample analysis for the first time: nanomaterial-conjugated direct assay and competitive assay.
Results and Discussions
Rational Design of NanoMIPs for Glycopeptide Antibiotic. The computational modelling software 
allows visualisation of binding interactions of the monomers with the vancomycin template (Supplementary 
information, Figs S1–S6). The modelling approach eliminates unsuitable monomer candidates and narrows down 
the selection of monomers that enormously reduce the real application time in the laboratory and the required 
cost for research13,22. Moreover, the use of monomers competing for the same binding site when two functional 
monomers are used in a recipe can be avoided by visualising the molecular interactions between the target mole-
cule and each monomer27. The individual monomers were docked to vancomycin target to calculate the binding 
energies and the highest binding energy was recorded for itaconic acid as the best functional monomer with 
−50.71 kcal mol−1 (Table 1). The highest negative binding energy scores represent the high affinity between the 
template and functional monomers.
NanoMIP Synthesis and Characterisation. The high affinity nanoMIPs were manufactured using solid 
phase synthesis method where vancomycin template was initially immobilised on the solid phase (Fig. 1A). The 
polymer mixture was poured on the glass beads and then exposed to UV light to perform the polymerisation. 
Low affinity polymers were discarded by applying cold wash and the high affinity nanoMIP receptors were col-
lected by carrying out hot wash in the last step.
The size and quality determination of the synthesised vancomycin nanoMIPs were carried out using the 
dynamic light scattering (DLS) method. The nanoMIPs produced as four separate batches were measured and 
their average size was found to be 174 ± 2.16 nm with a polydispersity index of 0.2. The lower PDI value is an 
indication for high quality and uniform nanoMIP samples9. The size and PDI values of each separate synthesis are 
given in Table 2. The correlation of raw data, data fit and size distribution by intensity were also evaluated to assess 
the reproducibility and reliability of the DLS results (Fig. 2). The correlation between the data of four separate 
syntheses confirms the consistency and stability of the nanoMIP receptors.
To determine the yield per production the vancomycin nanoMIP samples were concentrated by evaporating 
excess solvent under heating while agitating the solution with nitrogen gas. The total yield for each batch of nano-
MIP production was found to be around 15 mg that is a significant amount that allows conducting characterisa-
tion studies and sensor assays for a long time (Table 2).
Monomer
Abbreviation and 
charge of monomer
Binding energy 
(kcal mol−1)
Itaconic acid −IA −50.71
Trifluoromethacrylic acid −TFMAA −44.33
Methacrylic acid −MAA −43.41
Urocanic acid −UA −43.36
Ethylene glycol methachrylate phosphate EGMP −40.60
Diethylaminoethyl methacrylate +DEAEM −40.00
Hydroxyethyl methacrylate HEM −39.63
Methylene-bis-acrylamide MBAA −39.50
Acrylamide Acrylamide −37.67
Urocanic acid UA −34.44
Urocanic ethyl ester UAEE −32.00
1-vinylimidazole +VI −30.90
Ethylene glycol dimethacrylate EGDMA −28.55
Trifluoromethacrylic acid TFMAA −25.61
Table 1. Molecular modelling results depending on binding energy between the monomer and vancomycin 
target.
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NanoMIP-SPR Sensor for Vancomycin Detection in Milk. NanoMIP-SPR sensor was prepared by 
covalently immobilising the nanostructured polymeric receptors on the chip surface via amine coupling chemis-
try18,28. The surfaces of bare gold, thiol coated (11-mercaptoundecanoic acid: MUDA) and nanoMIP immobilised 
sensor chips were characterised using voltammetry techniques29. The ferrocynanide signal was largely suppressed 
after self-assembled monolayer formation using thiol solution indicating the successful coating of the chip with 
MUDA. The peak heights of cyclic voltammetry (CV) curves further decreased after nanoMIP immobilisation 
(Fig. 3A). The results of CV were also confirmed by square wave voltammetry (SWV) measurements that demon-
strated SWV peaks of 8.5 mA, 3.5 mA and 1.5 mA for bare, MUDA coated and nanoMIP immobilised surfaces, 
respectively (Fig. 3B).
Figure 1. Schematic illustrations of the preparation of vancomycin nanoMIPs (A) and their use in sensor 
development as synthetic affinity receptors for vancomycin detection (B).
NanoMIP
Diameter 
(nm)
Polydispersity 
(PDI)
Yield 
(mg)
Dissociation 
constant (Kd)
Batch 1 174 ± 9 0.2 15.2 1.3 × 10−9 M
Batch 2 176 ± 11 0.2 14.5 2.4 × 10−9 M
Batch 3 171 ± 5 0.2 15.6 1.1 × 10−9 M
Batch 4 175 ± 7 0.2 14.7 2.7 × 10−9 M
Table 2. Size, yield and affinity determination of nanoMIPs. Size of nanoMIPs and PDI values were determined 
using DLS. Affinity between nanoMIPs and vancomycin target is expressed as dissociation constant, which was 
calculated using Biacore 3000 analyzer.
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The initial bio-detection studies were carried out using free vancomycin without gold nanoparticle (AuNP) 
conjugation. This assay resulted in a detection limit of 50 μg mL−1 that is not sufficient enough to quantify the 
trace amounts of glycopeptide antibiotics in milk samples. To increase the sensitivity of the bio-detection assays 
the vancomycin target was conjugated with AuNPs. The samples were prepared in skimmed milk in the concen-
tration range of 5–1000 ng mL−1. The concentration dependent real time sensorgram of vancomycin assay is given 
in Fig. 4A and the overall results of vancomycin quantification is shown in Fig. 4B along with linear regression 
analysis, providing a R2 value of 0.96 that confirms the reproducibility of the assays. The LOD was verified based 
on the linear portion of the saturation graph by calculating three times standard deviation of the blank response 
(29.9 × 3 = 89.7 RU) and extrapolating the sensor signal in the linear calibration curve to convert the value to 
concentration. The limit of detection was determined to be 4.1 ng mL−1 with a linear range from 10 ng mL−1 to 
125 ng mL−1 as shown in Fig. 4B (inset). The sensitivity of nanoMIP-SPR sensor is sufficiently high for antibiotic 
quantification as MRL for antibiotics in milk ranges from 10 to 200 µg kg−1.
Furthermore, the kinetic data analysis was performed using Biacore 3000 analyzer to determine the affinity 
between the synthesised nanoMIPs and the vancomycin target. The calculation of dissociation constant (Kd) for 
each production of nanoMIPs was demonstrated in Table 2. The average dissociation constant was found to be 
around 1.8 × 10−9 M that indicates a high affinity between the nanoMIP receptors and vancomycin target. The 
affinity of vancomycin nanoMIPs is in good agreement with the previously reported drug nanoMIPs (1.48 × 10−9 
M for diclofenac; 1.35 × 10−10 M for metoprolol) that were used as synthetic receptors for drug monitoring 
in drinking water9,13. These sensors allowed quantifying diclofenac and metapolol down to 1.24 ng mL−1 and 
1.9 ng mL−1 using nanoparticle-conjugated assay approach, respectively. However, the matrix effect of drinking 
water is far less than milk samples and the production of MIPs for these drugs is easier due to their smaller size 
and less complex structures when compared to vancomycin.
The detection of other antibiotics in five times diluted milk samples was reported using a portable SPR sen-
sor that relied on haptenized proteins as bioreceptors5. The haptenized proteins were covalently attached to the 
sensing surface by means of a previously formed self-assembled monolayer. The sensor could quantify enroflox-
acin, sulfapyridine and chloramphenicol in the concentration ranges of 0.05–719 μg L−1, 0.03–499 μg L−1, and 
0.04–647 μg L−1 with LOD of 1.7 µg mL−1, 2.1 μg L−1, and 1.1 μg L−1, respectively. The sensitivity of this sensor is 
significantly lower than that of nanoMIP-SPR sensor in the current study as the authors used direct assay strat-
egy without nanomaterials that did not allow detecting maximum residue levels of some antibiotics (i.e. chlo-
ramphenicol)5. Other works carried out using Biacore instruments resulted in similar detection limits after the 
removal of matrix fat30. The sensitivity of sensor systems can be further increased up to 0.1 μg kg−1 when sample 
treatment or clean-up steps are applied31. Nevertheless, this approach still lacks of desired sensitivity and the need 
for nanoparticle-modified assay principle is clear.
The cross-reactivity of non-specific drug molecules (teicoplanin and artemisinin) to vancomycin nano-
MIPs was also accessed along with the background signal of the blank sample (skimmed milk without analytes) 
(Fig. 5A). The target and control drug samples prepared under the same conditions were injected to the vancomy-
cin nanoMIP immobilised sensor surfaces at the concentration range of 10–250 ng mL−1. Teicoplanin is another 
glycopeptide antibiotic that shows structural similarity to vancomycin (Fig. 5B). However, its interaction with 
the nanoMIP surface produced maximum 55 ± 2.4 RU response (corresponding result of 250 ng mL−1 teicopla-
nin sample injection), suggesting the specificity of the receptor cavities for vancomycin target in terms of shape, 
Figure 2. Size distribution analysis of nanoMIPs by intensity (A) and correlation analysis of data of four 
separate nanoMIP productions (B) using DLS method.
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size and chemical functionality. It is worth to mentioning that around 30 ± 2.4 RU sensor signal was recorded 
as a result of blank sample injection, meaning that only 25 RU signal change was produced upon the binding 
of teicoplanin on the nanoMIP immobilised surface for the highest concentration of the drug. Artemisinin is 
a small antimalarial drug that revealed a maximum signal of 32.5 ± 2.5 RU (corresponding to 250 ng mL−1 of 
artemisinin) upon interacting with the nanoMIP surface. This is most likely caused by much smaller size and 
considerably different structure of artemisinin when compared to vancomycin (Fig. 5B). The background signal 
of blank sample was also evaluated and it was found to be 30.3 ± 2.4 RU that was around three times lower than 
the signal of 10 ng mL−1 target binding.
A competitive bioassay was also performed in this work by mixing AuNP conjugated vancomycin 
and free vancomycin samples in skimmed milk to investigate the competition between vancomycin and 
AuNP-vancomycin. Eight different concentrations of vancomycin (10, 20, 40, 80, 160, 320, 500 and 1000 ng mL−1) 
in separate Eppendorf tubes were used and each sample was injected onto vancomycin-nanoMIP immobilised 
sensor surfaces for 4 min. A gradual decrease in sensor signal was observed with the increased concentration 
of free vancomycin molecules, indicating the successful development of a high affinity sensor method (Fig. 6). 
Also, the results of competitive assay confirmed that the binding of the AuNP conjugated target on the nanoMIP 
surface occurred via the interaction between vancomycin and the surface receptor.
To calculate the LOD of competitive assay, the sensor signals in Fig. 6B were initially converted to relative 
signal (%) to obtain the proportional relationship between the free vancomycin concentrations and the sensor 
response (Fig. 7). The relative signal for each free vancomycin concentration was calculated based on Equation 1:
Figure 3. Sensor surface characterisation using voltammetry techniques. Cyclic (A) and square wave 
voltammograms (B) recorded in 0.1 M K3Fe(CN)6 and 1 M KCI for bare gold chip (black curve), MUDA coated 
sensor chip surface (red curve) and nanoMIP immobilised sensor surface (pink curve).
www.nature.com/scientificreports/
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The conjugated vancomycin without the addition of free vancomycin produced 160 RU response, which is 10 
RU higher than that of the sample included the lowest free vancomycin concentration (10 ng mL−1) in addition 
to the conjugated vancomycin (150 RU). The Scatter graph in the concentration range of 10–1000 ng mL−1 was 
plotted (Fig. 7) and the LOD of the competitive assay was determined based on the linear portion of this plot 
(Fig. 7, inset) by calculating three times standard deviation of the blank response (3 × 8 = 24 RU). The LOD was 
determined to be 17.7 ng mL−1 with a linear range from 10 ng mL to 125 ng mL−1. The competitive assay can be 
used as an alternative method for antibiotic detection in milk samples. However, it is 1.77 time less sensitive than 
the threshold MRL concentration of antibiotics for milk (10 µg kg−1). The sensitivity of direct assay is 4.3 times 
higher than that of competitive assay. It is also worth mentioning that the reproducibility of the direct assay 
(R2 = 0.9697) is far better than the competitive assays (R2 = 0.7218) that is an important factor for the accuracy 
and reliability of the detection method.
To verify the accuracy of the sensor methods, the recovery studies were performed with a known quantity of 
vancomycin, which was previously determined for sensor methods, in the presence of milk. The samples were 
measured with sensor using direct and competitive assays before and after the addition of 5, 15 and 35 ng mL−1 
of vancomycin. The recoveries values for direct assay were determined to be 110%, 98% and 96% for 10, 20 and 
40 ng mL−1 concentrations of vancomycin respectively with acceptable relative standard deviations (RSDs) below 
3%. The slightly lower recoveries rates, ranging between 85% and 110%, were obtained with competitive assay 
with relatively higher RSDs (Table 3). All the recoveries rates were comprised between 80% and 110%32 (reference 
value suggested by the Association of Analytical Communities—AOAC), suggesting that both methods can reli-
ably be used for milk sample analysis. However, the nanoMIP-SPR sensor using direct assay demonstrated higher 
accuracy and can be applied very well for the analysis of this kind of sample without significant matrix effect.
Comparison of NanoMIP and NIP. This study has comparatively investigated the binding of vancomycin 
on non-imprinted polymer (NIP) and nanoMIP surfaces in the concentration range of 125–1000 ng mL−1 to 
further determine the specificity of the nanostructured polymeric receptors towards the target molecule. Each 
sample was injected onto two separate sensor surfaces for 4 min. Despite the surface could not be completely 
Figure 4. Concentration dependent real time sensorgram (A) and overall results of vancomycin detection 
assays in the range of 10–1000 ng mL−1 along with the linear regression analysis of the data revealed a R2 value 
of 0.96 (B).
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regenerated for subsequent analysis of different vancomycin concentrations in these assays, a significant dif-
ference was recorded for analyte binding on NIP and nanoMIP surfaces. The real time sensorgram of this test 
is shown in Fig. 8A. The data of three parallel experiments were subjected to the linear regression analysis that 
resulted in R2 values of 0.96 and 0.99 for nanoMIP and NIP, respectively (Fig. 8B). The imprinting factor was 
calculated based on the average sensor signals in the entire concentration range and it was determined as 7.4. 
An electro-synthesised MIP prepared for the detection of analgesic drug aminopyrine provided an imprinting 
factor of 6.67 and a detection limit of 0.13 mg mL−1 15. The MIP monolith, prepared by in situ thermal-initiated 
polymerisation for the determination of pefloxain (an antibacterial drug) from milk samples, was coupled with 
an HPLC system that revealed an imprinting factor of 3.1 and a limit of quantification of 4.7 ng mL−1. However, 
HPLC is a labour intensive technique and the sample pre-treatment was required33.
Materials and Methods
Materials and Reagents. 3-aminopropyltrimethyloxysilane (APTMS), glutaraldehyde, vancomycin 
hydrochloride, artemisinin, teicoplanin, N,N-diethyldithiocarbamate acid benzyl ester, itaconic acid, pentaer-
ylthirtol tetrakis(3-mercaptopropionte) 95% (chain transfer agent: CTA), trimethylolpropane trimethacrylate 
(TRIM), ethylene glycol dimethacrylate (EDGMA), acetonitrile, 60 mL SPE tubes and 20 μm pore frits, N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES) buffer, 11-mercaptoundecanoic acid (MUDA) 
95%, N-hydroxysuccinimide (NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), ethanolamine 
hydrochloride, gold nanoparticles (Au-NP), toluene, chloroform, 2-morpholinoethanesulfonic acid monohy-
drate (MES), N-(3-aminopropyl)methylacrylamide hydrochloride and phosphate buffered saline (PBS) were all 
obtained from Sigma Aldrich. Sodium hydroxide (NaOH) was purchased from VWR. Hexaferrocyanide (~ 99%, 
K3[Fe(CN)6]), potassium chloride (KCl) absolute ethanol were purchased from Roth. Micro glass beads were 
purchased from Blagden chemicals. Double-distilled ultrapure water was used for analyses.
Instrumentation and Apparatus. The size and stability of nanoMIPs were measured using dynamic light 
scattering (DLS) analysis with a Malvern Zetasizer NanoS instrument (Malvern Instruments). A fully automated 
SPR-based Biacore 3000 sensor (Uppsala, Sweden) was used for target detection assays and cross-reactivity stud-
ies. Bare gold sensor chips were obtained from Biacore GE Healthcare (Uppsala, Sweden). Surface characterisation 
Figure 5. Cross-reactivity analyses in the concentration range of 10–250 ng mL−1 using the target (vancomycin) 
and control drugs (artemisinin and teicoplanin). Blank represents the background signal of skimmed milk 
without any drug molecule (A). Chemical structures of three drugs used in this work (B).
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studies for bare gold chip, MUDA coated chip and MIP immobilised chips were performed using PalmSens4 
compact electrochemical interface with a three-electrode electrochemical system that was configured by con-
necting a gold working electrode, an Ag/AgCI reference electrode and a platinum wire as counter electrode in 
a cell with a volume of 5 mL (Belltec, Netherlands). Operating temperature of all instruments was 25 °C for the 
experiments. A sonicator and vortex from VWR (Dresden, Germany), were employed to dissolve the compounds.
Figure 6. Concentration dependent real time sensorgram (A) and overall results of competitive assay (B) in the 
concentration range of 10–1000 ng mL−1 (n = 3).
Figure 7. The proportional relationship between the free vancomycin concentrations and the sensor signal, and 
linear calibration plot of the vancomycin nanoMIP based sensor for competitive assay.
Contained vancomycin 
(ng mL−1)
Added vancomycin 
(ng mL−1)
Recovered vancomycin 
(ng mL−1)
Recovery 
(%) ± RSD
DA CA DA CA
5 5 11.0 9.5 110 ± 2 95 ± 6
5 15 19.6 17 98 ± 2 85 ± 7
5 35 38.5 35 96 ± 2 88 ± 7
Table 3. The recoveries rates of direct and competitive assays for milk samples spiked with vancomycin (n = 3). 
DA: Direct assay; CA: Competitive assay.
www.nature.com/scientificreports/
9Scientific RePoRTS |  (2018) 8:11222  | DOI:10.1038/s41598-018-29585-2
Rational Design of NanoMIPs Using Molecular Modelling. The workstation used for rational design 
of the synthetic receptors was an RM tower running Linux 6.2 operating system. The workstation was configured 
with 3.20 GHz Intel® Core TM i5-3470 processor, 320 GB hard drive and 8 GB RAM. This system was utilised for 
the software package SYBYL Tripos (St. Louis, Michigan, USA). The 2D structure of vancomycin was attained 
from the drug database. It was converted to 3D structure for minimisation. The molecule was then charged by the 
Gasteiger–Huckel method and the molecular mechanics was applied to minimise the structure using the Powell 
method. The minimisation was run until the convergence gradient reached 0.001 kcal mol−1. The procedure was 
fully described elsewhere13. A virtual library of 25 monomers characteristically used in molecular imprinting 
was screened using the LEAPFROG™ algorithm that exists within the modelling software13,22,23. The algorithm 
selected monomers according to the strongest binding interactions with the vancomycin target and then mini-
mised in organic solvents. The binding energy results were scaled from the highest binding scores to the lowest. 
The binding interactions between each functional monomer and the target template can be visualised by employ-
ing the software.
Preparation of Template Immobilised Solid Supports. Micro glass beads (60 g per production, 
45 μm < diameter < 90 μm) were vibrated with abrasive ceramic beads to eliminate any surface coating. The 
exposed surfaces of micro beads were then activated in 1 M NaOH during 10 min before thoroughly washing 
with double-distilled water at 60 °C. Another washing step was carried out with acetone at room temperature 
and the beads were then kept in an oven to dry (80 °C, 2 h). The dry glass beads were incubated overnight in a 2% 
v/v solution of 3-aminopropyltrimethyloxysilane (APTMS) in toluene at 4 °C to introduce amino groups to their 
surfaces. Subsequently the solution was removed, the glass beads were washed with double distilled water and 
dried for 1 h using the vacuum25.
To enable the binding of vancomycin template to the glass beads, aldehyde groups are required. Therefore, 
glutaraldehyde was coated on the silica surface of the glass beads. The aldehyde group of gluteraldehyde is able 
to make a covalent bond with an amine group of vancomycin, namely a peptide bond21. The activation step was 
performed by incubating 60 g of glass beads together with 50 mL of a phosphate buffered saline (PBS)- glutar-
aldehyde mixture during 2 h at room temperature. Hereof, 7% PBS has to be replaced by glutaraldehyde. Later 
on, the beads were washed with double-distilled water to remove the excess of gluteraldehyde. Subsequently, a 
0.5 mg mL−1 vancomycin prepared in PBS (50 mL, pH 7.4) was added to the glass beads. The glass beads were 
incubated overnight (4 °C) and unbound vancomycin was washed using deionised water followed by 15 min incu-
bation with ethanolamine (50 mL, 0.01 M) to cap any unreacted groups on glass bead to prevent from non-specific 
binding during the polymerisation. The template immobilised micro glass beads were rinsed with double distilled 
water and dried under vacuum, then stored at 4 °C.
NanoMIP Synthesis. The polymerisation mixture was prepared by mixing 2.18 g of itaconic acid as func-
tional monomer, 3.24 g ethylene glycol dimethacrylate (EDGMA) and 3.24 g of trimethylolpropane trimeth-
acrylate (TRIM) as cross-linkers, 0.18 g pentaerylthirtol tetrakis(3-mercaptopropionte) (CTA) as chain transfer 
agent and 0.753 g N,N-diethyldithiocarbamate acid benzyl ester as iniferter. The iniferter has three functions 
in the polymerisation process: initiator, transfer agent and terminator. All compounds were dissolved in ace-
tonitrile (10.52 g). The polymerisation mixture placed in a glass vial was purged with nitrogen for 20 min. 60 g 
Figure 8. Real time SPR sensorgram of vancomycin binding on nanoMIP and NIP immobilised surfaces (A). 
Comparison of overall nanoMIP and NIP assays (n = 3) (B).
www.nature.com/scientificreports/
1 0Scientific RePoRTS |  (2018) 8:11222  | DOI:10.1038/s41598-018-29585-2
of vancomycin derivatised glass beads was placed in 200 mL flat glass beaker and degassed under vacuum for 
15 min. The polymerisation solution was poured onto the glass beads that allow the functional monomer to bind 
to the vancomycin template via electrostatic interactions followed by polymerisation in the presence of the initi-
ator. Subsequently the mixture was exposed to UV light that triggered the polymerisation reaction. The exposure 
to UV light is a critical step in the production process and must be exactly 2 min. To add carboxyl group on the 
MIP, a 30 s polymerization was further performed using the secondary monomer [N-(3-aminopropyl) meth-
acrylamide hydrochloride] solution (5 mg monomer was dissolved in 7 mL of acetonitrile and then poured over 
the solid supports). Addition of carboxyl group to the MIP surface is essential for sensor construction, because 
nanoMIPs need to be covalently immobilised to the sensor chip surface9. After polymerisation the glass beads 
were transferred into SPE cartridge and washed six times using cold acetonitrile (0 °C) in an ice bath. Cold wash 
was carried out in order to remove low affinity polymeric structures and fragments. As the next step, the SPE 
cartridge was incubated in hot acetonitrile (60 °C) for 6 min and the high affinity nanoMIPs were then eluted 
from the solid phase. The last step was repeated five times to obtain a total volume of 150 mL high fraction of 
nanoMIPs. Non-imprinted polymer was also synthesised under the same conditions in the absence of target 
molecules to investigate the specificity of nanoMIPs for vancomycin target in terms of size, shape and chemical 
functionality of the cavities.
DLS Characterization of NanoMIPs. The size, stability and quality of nanoMIPs were determined by 
using the DLS method. DLS is also called as photon correlation spectroscopy and enables to determine the size 
and the distribution profile of particles and polymers in a solution. The measurements were realised using dis-
posable polystyrene cuvettes of 3 cm3, along with a Zetasizer Nano (Nano-S) at 25 °C. Before the analysis, the 
nanoMIP samples were prepared in 1 mL volume, sonicated for one minute and filtered through a 0.22 μm glass 
fibre filter, respectively.
NanoMIP-SPR Sensor for Bio-detection Assays. Sensor chip cleaning and SAM formation. SPR sen-
sor chips were cleaned using piranha solution. The chips were initially washed with ethanol and double dis-
tilled water, respectively. The piranha solution was prepared by pouring one part of hydrogen peroxide (H2O2) 
to three parts of sulphuric acid (H2SO4) in a glass vessel. The chips were immersed in this solution for 15 min. 
The solution was then removed after diluting it in 4 mL of double distilled water and the chips were washed with 
water until a pH of 6.0 was observed. Later on, the sensor chips were further rinsed with ethanol to remove all 
possible contaminants from the surface. After the cleaning process the SPR chips were directly immersed in 
2 mM MUDA solution prepared in absolute ethanol to form a self-assembled monolayer on the surface during 
overnight incubation.
Vancomycin detection assays using nanoMIP SPR sensor. MUDA coated sensor chips were docked to Biacore 
3000 system and primed with HEPES buffer (10 mM, pH 7.4). All sensor assays were carried out at room temper-
ature using HEPES solution as the running buffer at a flow rate of 10 µL min−1. The MUDA coated surface was 
activated by injecting the mixture of EDC (0.4 M) and NHS (0.1 M) in 1:1 volume ratio for 4 min. A 500 μg mL−1 of 
nanoMIPs in MES (pH 6.5), previously concentrated by evaporation, was then covalently attached to the surface 
during two subsequent injections (5 min per each injection). The nanoMIP-free surfaces were blocked by sub-
sequent injection of ethanolamine (0.1 M) for 4 min. Vancomycin samples were then prepared in milk and each 
sample was injected to the sensing surface for 4 min from the lowest concentration to the highest. The milk was 
defatted as described by Paniel et al.34 and the skimmed milk was used to prepare the vancomycin samples in the 
concentration range of 5–1000 ng mL−1. Kinetic data analysis was performed using Biacore 3000 analyzer to deter-
mine the affinity between nanoMIPs and vancomycin target, and it was expressed as dissociation constant (Kd).
Conjugation of pharmaceuticals with gold nanoparticles as signal amplification agents. Drugs are small molecules 
and their sensitive detection by sensors commonly requires the use of nanomaterials. Therefore, vancomycin 
was conjugated with gold nanoparticles to detect trace amounts of the drug in milk samples. The conjugation 
procedure was previously described in detail by Altintas et al.9. For cross-reactivity studies, non-specific drug 
molecules (artemisinin and teicoplanin) were also conjugated with AuNPs under the same conditions.
Sensor Surface Characterisation Using Voltammetry Techniques. The bare, MUDA coated and 
nanoMIP immobilised sensor surfaces were characterised using voltammetry techniques. For this PalmSens4 
compact electrochemical interface with a three-electrode electrochemical system was used by connecting SPR 
chip as a gold working electrode, an Ag/AgCI reference electrode and a platinum wire as auxiliary electrode 
in a cell with a volume of 5 mL. A 0.1 M ferrocyanide in 1 M KCl was used for cyclic voltammetry (CV) and 
square wave voltammetry (SWV) measurements. The potentials were cycled from −0.2 to + 0.8 V at a scan rate of 
50 mV/s for CV. The applied potentials for SWV were from −0.2 to + 0.8 V at a step height of 3 mV, an amplitude 
of 0.05 V, and a frequency of 10 Hz. All measurements were conducted at room temperature.
Conclusions
A new nanoMIP-SPR sensor for the detection of vancomycin in milk has been reported. NanoMIPs targeting 
vancomycin were rationally designed by employing computational simulations that enormously reduced the 
experimental screening time in the laboratory. The synthetic receptors were capable of detecting vancomycin in 
the range of 10–1000 ng mL−1 with high sensitivity and selectivity using an optical sensor. Taking into account 
that the MRL for antibiotics in milk ranges from 10 to 200 µg kg−1, the sensor demonstrates higher sensitivity 
than the threshold MRL level. The comparative investigations on nanoMIPs and NIPs demonstrated the great 
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selectivity of nanoMIPs towards their target molecule in terms of shape, size and chemical functionality and this 
was confirmed by an imprinting factor of 7.4. Cross-reactivity studies with other pharmaceuticals showed high 
specificity of nanoMIPs towards vancomycin. The affinity between the target drug and the synthetic receptors was 
found to be 1.8 × 10−9 M that is mostly higher than those of natural and other synthetic receptors for vancomy-
cin. The use of nanoMIP sensors in the field of food sample analysis for the detection of important contaminants 
offers cheap, easy-to-apply, reliable and fast bio-detection methods. The nanoMIP SPR may have immense impact 
both in food and health sectors.
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